National Institutes of Health
The National Institutes of Health (NIH) is a US federal agency funding biomedical research grants & programs.
NIH Grants: Fund Urgent Environmental Health Research
This NIH grant is for researchers facing unforeseen opportunities to collect critical environmental health data, like after disasters or policy changes. Secure rapid funding to investigate timely and scientifically valuable research questions.
NIH Grant: Fund Lung Cancer Screening Scale-Up
If you're involved in high-risk lung cancer screening, this NIH grant offers phased funding to develop and implement strategies for scaling up and sustaining these vital interventions across diverse settings and populations.
Fund Your Cancer Survivor Tobacco Treatment Research!
Seeking research projects to scale up and sustain tobacco use treatment for cancer survivors, especially those facing health inequities. This funding supports innovative trials to ensure equitable and effective delivery of these vital services.
NIH Grants: Fund Your Next Scientific Meeting!
This NIH grant helps researchers and institutions fund high-quality conferences and scientific meetings relevant to public health and NIH's mission. Secure funding to bring together experts and advance scientific knowledge.
Fund Your Research Career: NIH Grants Available
Are you a clinician looking to advance your research career in biomedical, behavioral, or clinical sciences? This NIH program offers funding for research education and mentoring networks to help you get involved in NIDCD research.
Fund Your Neurological Research & Development
NIH offers grants to businesses with validated biomarker candidates for neurological disorders. This funding supports rigorous clinical validation to meet FDA standards and establish predictive values.
Unlock Funding for Neurotherapeutics Development
Biotech companies focused on neurological disorders can get funding and expert support to advance their biologic-based drug discoveries from preclinical stages through Phase I clinical trials. This program helps you develop innovative therapies and retain intellectual property rights.
Get NIH Funding for Neurotherapeutics
This grant supports the preclinical discovery and development of biologic-based therapies for nervous system disorders, from lead optimization to early clinical trials. Eligible businesses will work with NIH experts to advance novel treatments and retain intellectual property rights.
Fund Your Cancer Prevention Breakthroughs: Up to $XXX,XXX
Seeking innovative businesses to discover and develop natural products for cancer interception and prevention. This grant funds the entire process, from target selection and assay validation to full-scale characterization and efficacy testing of promising agents.
NIH Grant: Boost Your Research Funding!
Are you a researcher focused on cellular immunity in the female reproductive tract? This NIH grant supports innovative basic research to understand T cell responses, aiming to pave the way for future vaccines against HIV and other viruses. We encourage investigators with relevant expertise, even if new to HIV research, to apply.
NIH Grants: Build/Upgrade Your Biomedical Research Lab!
Non-profit universities and research organizations can get funding to build new or upgrade existing biomedical research facilities. This grant aims to enhance your institution's capacity for groundbreaking medical research and development.
Unlock Funding for Aging Research: HIV & Substance Use Focus
This grant supports research into how mitochondria influence aging, immune deficiencies, HIV, and substance use disorders. The goal is to build knowledge that can lead to new treatments for individuals aging with these conditions.
Unlock Funding for HIV & SUD Aging Research
Seeking innovative research proposals to understand how mitochondrial function impacts aging in individuals with HIV and substance use disorders. This funding supports the development of new therapies to improve long-term health outcomes for these populations.
NIH Grants: Fund Cancer Prevention Research
Non-profits and research institutions can receive funding to coordinate and advance collaborative research in cancer immunoprevention. This grant supports data sharing, bioinformatic analysis, and fostering collaborations to accelerate breakthroughs in preventing cancer.
NIH Grant: Fund HIV Prevention Innovations
Researchers and small businesses can receive funding from the NIH to develop cutting-edge biomedical prevention methods and drug delivery systems for HIV. This program supports innovative approaches to create a sustainable pipeline of solutions for HIV prevention.
Fund Your Diabetes Research: NIH Grants Available!
If you're a research institution or clinic focused on Type 1 diabetes and kidney disease, this NIH grant can fund patient enrollment and critical research biopsies. The goal is to advance precision medicine and develop new therapies for diabetic nephropathy.
NIH Grants for ALS Drug Research & Patient Access
Are you a clinical trial site with a US FDA-designated sponsor for an ALS investigational drug? This NIH funding supports vital research using data from expanded access programs for intermediate ALS patient populations, accelerating treatment development.
Unlock Funding for HIV Prevention Innovations!
Seeking funding for cutting-edge, non-vaccine biomedical research to develop advanced HIV prevention methods like microbicides and PrEP. This grant supports projects exploring the microbiome, tissue responses, and the impact of bodily fluids on HIV susceptibility.
NIH Grant: Fund Your Neuroscience Research Tools!
Minority-serving and IDeA-eligible institutions can get funding to create and distribute specialized reagents for neuroscience research. This initiative aims to boost access to advanced tools for understanding brain cell types and circuits.
Unlock Drug Discovery Funding: NIH Grants for Neurotherapeutics
Are you a neuroscience investigator with a promising small molecule drug discovery for nervous system disorders? This NIH program offers funding to advance your research from early discovery to clinical trials, with expert collaboration and IP rights retention.